Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Wu Skincare CoROCO:6523 82 Debt-to-Equity is 0.03 as of Jun. 2026, which is 50% above its 10-year median of 0.02. GuruFocus rates ROCO:6523 with a GF Score™ of 82/100 and a GF Value™ of NT$131.40 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,764 Consumer Packaged Goods companies, Dr Wu Skincare Co ranks better than 92.86% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Dr Wu Skincare Co's Debt-to-Equity or its related term are showing as below:
ROCO:6523'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.03
Current: 0.03
During the past 13 years, the highest Debt-to-Equity Ratio of Dr Wu Skincare Co was 0.03. The lowest was 0.00. And the median was 0.02.
ROCO:6523's Debt-to-Equity is ranked better than 92.86% of 1764
companies
in the Consumer Packaged Goods industry
Industry Median: 0.41
vs ROCO:6523: 0.03
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Dr Wu Skincare Co Debt-to-Equity Related Terms
Dr Wu Skincare Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Dr Wu Skincare Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6523 vs PG, CL, EL: Debt-to-Equity Comparison
For the Household & Personal Products subindustry, Dr Wu Skincare Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Wu Skincare Co Debt-to-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Wu Skincare Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Dr Wu Skincare Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Wu Skincare Co (ROCO:6523) has a Debt-to-Equity of 0.03 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Dr Wu Skincare Co and its competitors. This is 50% above median its historical median of 0.02. According to the industry distribution chart, Dr Wu Skincare Co ranks #126 out of 1764 companies in the Consumer Packaged Goods industry, placing it in the top 7.1%.
Is Dr Wu Skincare Co's Debt-to-Equity too high?
Dr Wu Skincare Co's current Debt-to-Equity of 0.03 is 50% above median its 10-year median of 0.02. The Consumer Packaged Goods industry median Debt-to-Equity is 0.41. Dr Wu Skincare Co's value of 0.03 is 92.7% below this industry median. Based on the distribution chart, Dr Wu Skincare Co ranks #126 out of 1764 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Dr Wu Skincare Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Wu Skincare Co's Debt-to-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Dr Wu Skincare Co ranks #126 out of 1764 companies for Debt-to-Equity. This places Dr Wu Skincare Co in the top 7% of its industry — outperforming the majority of peers. The industry median Debt-to-Equity is 0.41. Dr Wu Skincare Co's value of 0.03 is 92.7% below this benchmark. While the company's 10-year median is 0.02 vs. the industry median of 0.41, Dr Wu Skincare Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Consumer Packaged Goods company?
The median Debt-to-Equity among Consumer Packaged Goods companies is 0.41, based on 1,764 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Wu Skincare Co's current Debt-to-Equity of 0.03 is 92.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Dr Wu Skincare Co and its competitors. For the Consumer Packaged Goods industry, the median Debt-to-Equity is 0.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Wu Skincare Co's current Debt-to-Equity is 0.03, which is 50% above median its own 10-year median of 0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Wu Skincare Co stock overvalued right now?
Based on GuruFocus' analysis, Dr Wu Skincare Co (ROCO:6523) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$131.40, compared to a current price of NT$89.70 — trading 31.7% below its estimated fair value. The current Debt-to-Equity is 0.03, which is 50% above median its 10-year median of 0.02 and 92.7% below the Consumer Packaged Goods industry median of 0.41. Dr Wu Skincare Co's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Dr Wu Skincare Co (ROCO:6523), the current Debt-to-Equity is 0.03 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Wu Skincare Co (ROCO:6523) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Wu Skincare Co stock appears to be undervalued.
The current stock price of NT$89.70 is trading 31.7% below its estimated GF Value™ of NT$131.40.
GuruFocus considers Dr Wu Skincare Co to be Significantly Undervalued.
Key valuation signals for ROCO:6523:
Debt-to-Equity: 0.03 (50% above median its 10-year median of 0.02)
GF Value™: NT$131.40 vs. price of NT$89.70 (31.7% below fair value)
Industry Position: 92.7% below the Consumer Packaged Goods median (#126 of 1764)
No single metric tells the full story. See the ROCO:6523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Wu Skincare Co Ltd is a Taiwan based company engaged in the research, development, production, wholesale and retail of cosmetics. It principally manufactures and sells cosmetics. The company offers products such as cosmetic masks, lotions, eye care products, moisturizers and others. The group derives its revenue from the sales of private label care products. It sells the products in Taiwan and internationally, of which majority of the revenue is derived from the sales made in Taiwan.
82GF Score
Get the complete analysis for ROCO:6523
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6523 has been successfully added to your 
